- Home
- GPMT vs HLVX Comparison
GPMT vs HLVX Comparison
Compare GPMT & HLVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPMT
- HLVX
- Stock Information
- Founded
- GPMT 2015
- HLVX 2020
- Country
- GPMT United States
- HLVX United States
- Employees
- GPMT N/A
- HLVX N/A
- Industry
- GPMT Real Estate Investment Trusts
- HLVX Biotechnology: Pharmaceutical Preparations
- Sector
- GPMT Real Estate
- HLVX Health Care
- Exchange
- GPMT Nasdaq
- HLVX Nasdaq
- Market Cap
- GPMT 122.0M
- HLVX 104.3M
- IPO Year
- GPMT 2017
- HLVX 2022
- Fundamental
- Price
- GPMT $2.85
- HLVX $2.08
- Analyst Decision
- GPMT Buy
- HLVX Hold
- Analyst Count
- GPMT 3
- HLVX 1
- Target Price
- GPMT $3.13
- HLVX $2.00
- AVG Volume (30 Days)
- GPMT 256.5K
- HLVX 777.1K
- Earning Date
- GPMT 08-05-2025
- HLVX 08-06-2025
- Dividend Yield
- GPMT 6.99%
- HLVX N/A
- EPS Growth
- GPMT N/A
- HLVX N/A
- EPS
- GPMT N/A
- HLVX N/A
- Revenue
- GPMT N/A
- HLVX N/A
- Revenue This Year
- GPMT N/A
- HLVX N/A
- Revenue Next Year
- GPMT $26.51
- HLVX N/A
- P/E Ratio
- GPMT N/A
- HLVX N/A
- Revenue Growth
- GPMT N/A
- HLVX N/A
- 52 Week Low
- GPMT $1.61
- HLVX $1.34
- 52 Week High
- GPMT $3.66
- HLVX $2.17
- Technical
- Relative Strength Index (RSI)
- GPMT 57.26
- HLVX 51.41
- Support Level
- GPMT $2.77
- HLVX $2.07
- Resistance Level
- GPMT $2.90
- HLVX $2.13
- Average True Range (ATR)
- GPMT 0.08
- HLVX 0.03
- MACD
- GPMT 0.00
- HLVX -0.00
- Stochastic Oscillator
- GPMT 78.72
- HLVX 37.50
About GPMT Granite Point Mortgage Trust Inc.
Granite Point Mortgage Trust Inc focuses on directly originating, investing in, and managing senior floating rate commercial mortgage loans and other debt and debt-like commercial real estate investments. The company constructs its investment portfolio on a loan-by-loan basis, emphasizing rigorous credit underwriting, selectivity, and diversification, and assesses each investment from a fundamental value perspective relative to other opportunities available in the market. It typically provides intermediate-term bridge or transitional financing for a variety of purposes, including acquisitions, recapitalizations, refinancing, and a range of business plans, including lease-up, renovation, repositioning and repurposing of the property.
About HLVX HilleVax Inc.
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.